glp-1 drug interactions mechanism of action of analogues, DPP-IV inhibitors, and Trends in the Development of
Description
Other oral compounds like CT-996 / RG 6652 showed a clinically meaningful weight reduction of 6-7% in four weeks among participants without T2D, and GSBR-1290 has demonstrated favourable safety, tolerability and efficacy results
Whats Next for Compounded GLP-1 Drugs
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
This article looks at the unwanted side effects of glucagon-like peptide-1 (GLP-1) receptor agonists
